Rheumatoid Arthritis - All SharePosts Relating To "Alert"

EXPERT

Christine Miller

posted 02/02/2007, comments (0)

Individualization and Follow-up are Key to Successful Exercise Pr

A recent article in the online December issue of Arthritis & Rheumatism compared the effectiveness of two different types of Internet-based physical activity interventions for people with rheumatoid arthritis. In this study from the Netherlands, 160 patients were monitored over a period of a year. The patients were divided into two groups... Read more Chevron

Read all my posts | Subscribe | Send Message

EXPERT

Mark Borigini, M.D.

(Profile)

Rheumatologist

Our Expert | Health Professional

RSS

posted 02/01/2007, comment (1)

New Worries About A New Rheumatoid Arthritis Drug

On December 19, 2006, the United States Food and Drug Administration issued an “Alert” regarding the safety of Rituxan use in patients suffering from rheumatologic illnesses.This alert was issued because there were two reported cases of fatal Progressive Multifocal Leukoencepholopathy, more conveniently referred to as PML. And while these... Read more Chevron

Read all my posts | Subscribe | Send Message

EXPERT

Christine Miller

(Profile)

Our Expert | Caregiver

RSS

posted 01/17/2007, comments (0)

Vioxx Heart Attack Risk Linked to Blood Clotting

A recent study may provide hope that scientists will one day be able to develop COX-2 inhibitor drugs, such as Celebrex and Vioxx, that do not have the associated risk of heart attacks and strokes. The research, published in the December issue of the Federation of American Societies for Experimental Biology (FASEB), found that Vioxx and the... Read more Chevron

Read all my posts | Subscribe | Send Message

EXPERT

Christine Miller

(Profile)

Our Expert | Caregiver

RSS

posted 12/05/2006, comments (0)

Potent Anti-HIV Drugs Associated with Arthritis

New research presented at the November 2006 American College of Rheumatology meeting in Washington and discussed on Aidsmap, shows that arthritis and connective tissue disease are unexpectedly more likely in people with HIV taking potent anti-HIV therapy. The two studies presented on the subject were from the U.K and the U.S. Before effective... Read more Chevron

Read all my posts | Subscribe | Send Message

EXPERT

Christine Miller

(Profile)

Our Expert | Caregiver

RSS

posted 12/01/2006, comments (0)

FDA Arthritis Advisory Committee Recommends Approval of Celebrex

On Wednesday, November 29, the Food and Drug Administration’s independent Arthritis Advisory Committee met to discuss the safety and efficacy of celecoxib, a nonsteriodal anti-inflammatory drug (COX-2 inhibitor). Celecoxib is marketed as Celebrex stuby Pfizer, Inc. The FDA approved the drug for use in adults with osteoarthritis and... Read more Chevron

Read all my posts | Subscribe | Send Message